LLY DEF 14A DEF-14A Report March 19, 2018 | Alphaminr
ELI LILLY & Co

LLY DEF 14A Report ended March 19, 2018

ELI LILLY & CO
10-Ks and 10-Qs
10-Q
Quarter ended March 31, 2024
10-K
Fiscal year ended Dec. 31, 2023
10-Q
Quarter ended Sept. 30, 2023
10-Q
Quarter ended June 30, 2023
10-Q
Quarter ended March 31, 2023
10-K
Fiscal year ended Dec. 31, 2022
10-Q
Quarter ended Sept. 30, 2022
10-Q
Quarter ended June 30, 2022
10-Q
Quarter ended March 31, 2022
10-K
Fiscal year ended Dec. 31, 2021
10-Q
Quarter ended Sept. 30, 2021
10-Q
Quarter ended June 30, 2021
10-Q
Quarter ended March 31, 2021
10-K
Fiscal year ended Dec. 31, 2020
10-Q
Quarter ended Sept. 30, 2020
10-Q
Quarter ended June 30, 2020
10-Q
Quarter ended March 31, 2020
10-K
Fiscal year ended Dec. 31, 2019
10-Q
Quarter ended Sept. 30, 2019
10-Q
Quarter ended June 30, 2019
10-Q
Quarter ended March 31, 2019
10-K
Fiscal year ended Dec. 31, 2018
10-Q
Quarter ended Sept. 30, 2018
10-Q
Quarter ended June 30, 2018
10-Q
Quarter ended March 31, 2018
10-K
Fiscal year ended Dec. 31, 2017
10-Q
Quarter ended Sept. 30, 2017
10-Q
Quarter ended June 30, 2017
10-Q
Quarter ended March 31, 2017
10-K
Fiscal year ended Dec. 31, 2016
10-Q
Quarter ended Sept. 30, 2016
10-Q
Quarter ended June 30, 2016
10-Q
Quarter ended March 31, 2016
10-K
Fiscal year ended Dec. 31, 2015
10-Q
Quarter ended Sept. 30, 2015
10-Q
Quarter ended June 30, 2015
10-Q
Quarter ended March 31, 2015
10-K
Fiscal year ended Dec. 31, 2014
10-Q
Quarter ended Sept. 30, 2014
10-Q
Quarter ended June 30, 2014
10-Q
Quarter ended March 31, 2014
10-K
Fiscal year ended Dec. 31, 2013
10-Q
Quarter ended Sept. 30, 2013
10-Q
Quarter ended June 30, 2013
10-Q
Quarter ended March 31, 2013
10-K
Fiscal year ended Dec. 31, 2012
10-Q
Quarter ended Sept. 30, 2012
10-Q
Quarter ended June 30, 2012
10-Q
Quarter ended March 31, 2012
10-K
Fiscal year ended Dec. 31, 2011
10-Q
Quarter ended Sept. 30, 2011
10-Q
Quarter ended June 30, 2011
10-Q
Quarter ended March 31, 2011
10-K
Fiscal year ended Dec. 31, 2010
10-Q
Quarter ended Sept. 30, 2010
10-Q
Quarter ended June 30, 2010
10-Q
Quarter ended March 31, 2010
10-K
Fiscal year ended Dec. 31, 2009
PROXIES
DEF 14A
Filed on March 22, 2024
DEF 14A
Filed on March 17, 2023
DEF 14A
Filed on March 18, 2022
DEF 14A
Filed on March 19, 2021
DEF 14A
Filed on March 20, 2020
DEF 14A
Filed on March 22, 2019
DEF 14A
Filed on March 19, 2018
DEF 14A
Filed on March 20, 2017
DEF 14A
Filed on March 21, 2016
DEF 14A
Filed on March 23, 2015
DEF 14A
Filed on March 24, 2014
DEF 14A
Filed on March 29, 2013
DEF 14A
Filed on March 5, 2012
DEF 14A
Filed on March 7, 2011
DEF 14A
Filed on March 8, 2010
TABLE OF CONTENTS
Notice of Annual Meeting of Shareholders P1Proxy Statement Summary P2Governance P11Item 1 - Election of Directors P11Board Operations and Governance P11Director Qualifications and Nomination Process P19Director Compensation P21Director Independence P23Committees of the Board of Directors P24Membership and Meetings of the Board and Its Committees P25Board Oversight of Compliance and Risk Management P27Highlights of the Company's Corporate Governance P27Shareholder Engagement on Governance Issues P31Prior Management Proposals to Eliminate Classified Board and Supermajority Voting Requirements P31Shareholder Proposals and Nominations P32Ownership of Company Stock P33Compensation P34Item 2 - Advisory Vote on Compensation Paid to Named Executive Officers P34Compensation Discussion and Analysis P35Executive Compensation P50Compensation Committee Matters P60Audit Matters P62Item 3 - Proposal to Ratify the Appointment of Principal Independent Auditor P62Management Proposals P65Item 4 - Amend Articles of Incorporation to Eliminate the Classified Board Structure P65Item 5 - Amend Articles of Incorporation to Eliminate Supermajority Voting Provisions P66Item 6 - Approve the Amended and Restated 2002 Lilly Stock Plan P68Shareholder Proposals P77Item 7 - Seeking Support for the Descheduling of Cannabis P77Item 8 - Requesting Report Regarding Direct and Indirect Political Contributions P78Item 9 - Requesting Report on Policies and Practices Regarding Contract Animal Laboratories P80Item 10 - Requesting Report on Extent to Which Risks Related to Public Concern Over Drug Pricing Strategies are Integrated into Incentive Compensation Arrangements P82Other Information P83Meeting and Voting Logistics P83Other Matters P86Appendix A - Summary of Adjustments Related to the Annual Cash Bonus and Performance Award P87Appendix B - Proposed Amendments to the Company's Articles of Incorporation P89Appendix C - Proposed Amended and Restated 2002 Lilly Stock Plan P93Annual Meeting Admission Ticket P112